Boothbay Fund Management, LLC Immunovant, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

A detailed history of Boothbay Fund Management, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 150,200 shares of IMVT stock, worth $4.13 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
150,200
Previous 64,796 131.8%
Holding current value
$4.13 Million
Previous $1.71 Million 141.64%
% of portfolio
0.11%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$25.1 - $31.61 $5,547 - $6,985
-221 Reduced 0.34%
64,796 $1.71 Million
Q1 2024

May 15, 2024
BUY
$30.27 - $43.79 $466,975 - $675,548
15,427 Added 31.11%
65,017 $2.1 Million
Q4 2023

Feb 14, 2024
SELL
$31.31 - $44.19 $172,705 - $243,752
-5,516 Reduced 10.01%
49,590 $2.09 Million
Q3 2023

Nov 14, 2023
BUY
$18.55 - $39.96 $1.02 Million - $2.2 Million
55,106 New
55,106 $2.12 Million
Q1 2023

May 15, 2023
SELL
$15.27 - $19.72 $586,184 - $757,011
-38,388 Reduced 21.76%
138,000 $2.14 Million
Q4 2022

Feb 14, 2023
BUY
$6.59 - $17.75 $225,727 - $607,990
34,253 Added 24.1%
176,388 $3.13 Million
Q3 2022

Nov 14, 2022
BUY
$3.93 - $6.37 $558,590 - $905,399
142,135 New
142,135 $793,000
Q4 2021

Feb 14, 2022
SELL
$7.33 - $9.32 $236,267 - $300,411
-32,233 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$7.01 - $11.37 $89,209 - $144,694
-12,726 Reduced 28.31%
32,233 $280,000
Q2 2021

Aug 16, 2021
BUY
$9.4 - $16.85 $422,614 - $757,559
44,959 New
44,959 $475,000
Q1 2021

May 17, 2021
SELL
$13.08 - $49.6 $373,669 - $1.42 Million
-28,568 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$36.36 - $52.71 $380,471 - $551,557
-10,464 Reduced 26.81%
28,568 $1.32 Million
Q3 2020

Nov 16, 2020
BUY
$22.61 - $38.9 $79,700 - $137,122
3,525 Added 9.93%
39,032 $1.37 Million
Q2 2020

Aug 14, 2020
SELL
$13.87 - $28.44 $1.17 Million - $2.39 Million
-84,097 Reduced 70.31%
35,507 $865,000
Q1 2020

May 15, 2020
BUY
$8.36 - $17.13 $292,106 - $598,539
34,941 Added 41.27%
119,604 $1.86 Million
Q4 2019

Feb 14, 2020
BUY
$10.02 - $16.4 $848,323 - $1.39 Million
84,663 New
84,663 $1.34 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email